Clear Scientific, CS-1103, Fentanyl, Opioid Overdose, Drug Development, Phase 2 Clinical Trial, Clinical Research, Sm

Cambridge, Massachusetts, U.S., October 5, 2026 Clear Scientific, Inc. has reported positive top-line Phase 2 results for CS-1103, an...